State of Alaska Department of Revenue boosted its holdings in Envista Holdings Co. (NYSE:NVST – Free Report) by 7.3% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,887 shares of the company’s stock after acquiring an additional 1,355 shares during the quarter. State of Alaska Department of Revenue’s holdings in Envista were worth $392,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of NVST. William Blair Investment Management LLC raised its stake in Envista by 4.0% in the first quarter. William Blair Investment Management LLC now owns 14,049 shares of the company’s stock valued at $300,000 after purchasing an additional 538 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock worth $35,000 after buying an additional 726 shares during the last quarter. Allspring Global Investments Holdings LLC raised its position in shares of Envista by 50.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after buying an additional 728 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Envista by 2.3% during the 2nd quarter. Victory Capital Management Inc. now owns 36,021 shares of the company’s stock worth $599,000 after acquiring an additional 800 shares during the last quarter. Finally, Blue Trust Inc. grew its position in Envista by 69.7% in the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after acquiring an additional 804 shares in the last quarter.
Envista Price Performance
Shares of NVST stock opened at $20.39 on Friday. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The business’s 50 day moving average price is $18.88 and its 200-day moving average price is $18.12. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $25.64.
Analyst Ratings Changes
Several brokerages have issued reports on NVST. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and lifted their price target for the stock from $16.00 to $23.00 in a research note on Thursday, October 31st. Stifel Nicolaus boosted their target price on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research report on Thursday, October 31st. Robert W. Baird boosted their price objective on shares of Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Finally, Wells Fargo & Company began coverage on shares of Envista in a report on Tuesday, October 8th. They set an “equal weight” rating and a $20.00 target price on the stock. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $20.71.
View Our Latest Analysis on NVST
Insiders Place Their Bets
In other news, CFO Eric D. Hammes bought 24,532 shares of Envista stock in a transaction on Monday, August 12th. The shares were purchased at an average price of $16.33 per share, for a total transaction of $400,607.56. Following the acquisition, the chief financial officer now owns 24,532 shares of the company’s stock, valued at approximately $400,607.56. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.30% of the stock is currently owned by company insiders.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Recommended Stories
- Five stocks we like better than Envista
- Stock Splits, Do They Really Impact Investors?
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- Manufacturing Stocks Investing
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.